BlackRock Investment Management’s Stemline Therapeutics, Inc. STML Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $790K | Sell |
73,870
-23
| -0% | -$246 | ﹤0.01% | 2824 |
|
|
2016
Q3 | $800K | Buy |
73,893
+7,800
| +12% | +$84.4K | ﹤0.01% | 2791 |
|
|
2016
Q2 | $447K | Buy |
66,093
+7,676
| +13% | +$51.9K | ﹤0.01% | 3103 |
|
|
2016
Q1 | $272K | Buy |
58,417
+290
| +0.5% | +$1.35K | ﹤0.01% | 3083 |
|
|
2015
Q4 | $367K | Buy |
58,127
+193
| +0.3% | +$1.22K | ﹤0.01% | 3098 |
|
|
2015
Q3 | $512K | Sell |
57,934
-468
| -0.8% | -$4.14K | ﹤0.01% | 3006 |
|
|
2015
Q2 | $687K | Buy |
58,402
+15,264
| +35% | +$180K | ﹤0.01% | 3000 |
|
|
2015
Q1 | $624K | Buy |
43,138
+9,195
| +27% | +$133K | ﹤0.01% | 2828 |
|
|
2014
Q4 | $579K | Sell |
33,943
-115
| -0.3% | -$1.96K | ﹤0.01% | 2927 |
|
|
2014
Q3 | $424K | Buy |
34,058
+769
| +2% | +$9.57K | ﹤0.01% | 3045 |
|
|
2014
Q2 | $488K | Buy |
33,289
+6,426
| +24% | +$94.2K | ﹤0.01% | 3042 |
|
|
2014
Q1 | $547K | Buy |
26,863
+631
| +2% | +$12.8K | ﹤0.01% | 2890 |
|
|
2013
Q4 | $514K | Buy |
26,232
+305
| +1% | +$5.98K | ﹤0.01% | 2920 |
|
|
2013
Q3 | $1.17M | Buy |
25,927
+2,099
| +9% | +$95K | ﹤0.01% | 2317 |
|
|
2013
Q2 | $568K | Buy |
+23,828
| New | +$568K | ﹤0.01% | 2769 |
|